Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice

British Journal of Nutrition

Volumn 111, Issue 9, 2014, Pages 1611-1621

  Justino, Priscilla F C ^a   Melo, Luis F M ^a   Nogueira, Andre F ^a   Costa, Jose V G ^a   Silva, Luara M N ^a   Santos, Cecila M ^a   Mendes, Walber O ^a   Costa, Marina R ^a   Franco, Alvaro X ^a   Lima, Aldo A ^a   Ribeiro, Ronaldo A ^a   Souza, Marcellus H L P ^a   Soares, Pedro M G ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

5 Fluorouracil; Inflammation; Intestinal mucositis; Probiotics; Saccharomyces boulardii

Indexed keywords

CXCL1 CHEMOKINE; FLUOROURACIL; GLUTATHIONE; INTERLEUKIN 1BETA; LACTULOSE; MANNITOL; MYELOPEROXIDASE; NITRITE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; GASTROINTESTINAL TRANSIT; ILEUM; INTESTINAL MUCOSITIS; INTESTINE ABSORPTION; INTESTINE CRYPT; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; JEJUNUM; LEUKOPENIA; MALE; MOUSE; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; SACCHAROMYCES BOULARDII; STOMACH EMPTYING; WEIGHT REDUCTION;

MURINAE; MUS; SACCHAROMYCES BOULARDII;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FECES; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GLUTATHIONE; ILEUM; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MALE; MICE; MUCOSITIS; NEUTROPHIL INFILTRATION; NITRIC OXIDE; PEROXIDASE; PREBIOTICS; RANDOM ALLOCATION; SACCHAROMYCES;

EID: 84897990086     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513004248     Document Type: Article

References (52)

1. Fuller R (1991) Probiotics in human medicine. Gut 32, 439-442
2. Laudanno O, Vasconcelos L, Catalana J, et al. (2006) Antiinflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria. Dig Dis Sci 51, 2180-2183
3. Dieleman LA, Goerres MS, Arends A, et al. (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52, 370-376
4. Jespersen L (2003) Occurrence and taxonomic characteristics of strains of Saccharomyces cerevisiae predominant in African indigenous fermented foods and beverages. FEMS Yeast Res 3, 191-200
5. Buts JP & De Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51, 1485-1492
6. Buts JP, Stilmant C, Bernasconi P, et al. (2008) Characterization of a,a-Trehalase released in the intestinal lumen by the probiotic Saccharomyces boulardii. Scand J Gastroenterol 43, 1489-1496
7. Sezer A, Usta U & Cicin I (2009) The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea. Med Oncol 26, 350-357
8. Duncan M & Grant G (2003) Oral and intestinal mucositis -causes and possible treatments. Aliment Pharmacol Ther 18, 853-874
9. Longley DB, Harkin DP & Johnston PG (2003) 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 3, 330-338
10. Sonis ST (1998) Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34, 39-43
11. Baerg J, Murphy JJ, Anderson R, et al. (1999) Neutropenic enteropathy: A 10-year review. J Pediatr Surg 34, 1068-1071
12. Keefe DM, Gibson RJ & Hauer-Jensen M (2004) Gastrointestinal mucositis. Semin Oncol Nurs 20, 38-47
13. Soares PM, Mota JM, Gomes AS, et al. (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63, 91-98
14. MacPherson BR & Pfeiffer CJ (1978) Experimental production of diffuse colitis in rats. Digestion 17, 135-150
15. Bradley PP, Christensen RD & Rothstein G (1982) Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60, 618-622
16. Sedlak J & Lindsay RH (1968) Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25, 192-205
17. Chen SM, Swilley S, Bell R, et al. (2000) Lead induced alterations in nitrite and nitrate levels in Different regions of the rat brain. Comp Biochem Physiol C Toxicol Pharmacol 125, 315-323
18. Reynell PC & Spray GH (1958) Chemical gastroenteritis in the rat. Gastroenterology 34, 867-873
19. Lima AA, Silva TM, Gifoni AM, et al. (1997) Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil. Am J Gastroenterol 92, 1861-1866
20. Pearson AD, Eastham EJ, Laker MF, et al. (1982) Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) 285, 20-21
21. Deitch EA (1990) Intestinal permeability is increased in burn patients shortly after injury. Surgery 107, 411-416
22. Sonis ST, Elting LS, Keefe D, et al. (2004) Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995-2025
23. Rubenstein EB, Peterson DE, Schubert M, et al. (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100, 2026-2046
24. Edens HA, Levi BP, Jaye DL, et al. (2002) Neutrophil transepithelial migration: Evidence for sequential, contactdependent signaling events and enhanced paracellular permeability independent of transjunctional migration. J Immunol 169, 476-486
25. Lima V, Brito GA, Cunha FQ, et al. (2005) Effects of the tumour necrosis factor-A inhibitors pentoxifylline and thalidomide in short-Term experimental oral mucositis in hamsters. Eur J Oral Sci 113, 210-217
26. Carneiro-Filho BA, Oria RB, Wood Rea K, et al. (2004) Alanylglutamine hastens morphologic recovery from 5-fluorouracilinduced mucositis in mice. Nutrition 20, 934-941
27. Petschow BW, Carter DL & Hutton GD (1993) Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats. J Pediatr Gastroenterol Nutr 17, 49-58
28. Orazi A, Du X, Yang Z, et al. (1996) Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75, 33-42
29. Prisciandaro LD, Geier MS, Butler RN, et al. (2011) Probiotic factors partially improve parameters of 5-fluorouracilinduced intestinal mucositis in rats. Cancer Biol Ther 11, 671-677
30. Smith CL, Geier MS, Yazbeck R, et al. (2008) Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer 60, 757-767
31. Girard P, Coppe MC, Pansart Y, et al. (2010) Gastroprotective effect of Saccharomyces boulardii in a rat model of ibuprofen-induced gastric ulcer. Pharmacology 85, 188-193
32. Wu X, Vallance BA, Boyer L, et al. (2008) Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 294, G295-G306
33. Canonici A, Siret C, Pellegrino E, et al. (2011) Saccharomyces boulardii improves intestinal cell restitution through activation of the a2b1 integrin collagen receptor. PLoS ONE 6, e18427
34. Melo ML, Brito GA, Soares RC, et al. (2008) Role of cytokines (TNF-A, IL-1b and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: Ffect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 61, 775-784
35. Soares PM, Lima-Junior RC, Mota JM, et al. (2010) Role of platelet-Activating factor in the pathogenesis of 5-fluorouracilinduced intestinal mucositis in mice. Cancer Chemother Pharmacol 68, 713-720
36. Fidan I, Kalkanci A, Yesilyurt E, et al. (2009) Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans. Mycoses 52, 29-34
37. Lee SK, Kim YW, Chi SG, et al. (2009) The effect of Saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci 54, 255-263
38. Wu ZQ, Han XD, Wang Y, et al. (2011) Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Cancer Chemother Pharmacol 68, 87-96
39. Yasuda M, Kato S, Yamanaka N, et al. (2012) Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Am J Physiol Gastrointest Liver Physiol 302, G1133-G1142
40. Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4, 277-284
41. Riezzo G, Clemente C, Leo S, et al. (2005) The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms. J Gastroenterol 40, 1107-1115
42. Hollander D (1999) Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1, 410-416
43. van Vliet MJ, Harmsen HJ, de Bont ES, et al. (2010) The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6, e1000879
44. Wardill HR & Bowen JM (2013) Chemotherapy-induced mucosal barrier dysfunction: An updated review on the role of intestinal tight junctions. Curr Opin Support Palliat Care 7, 155-161
45. Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, et al. (2008) Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol 43, 842-848
46. Massi M, Ioan P, Budriesi R, et al. (2006) Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol 12, 5987-5994
47. Czerucka D & Rampal P (2002) Experimental effects of Saccharomyces boulardii on Diarrheal pathogens. Microbes Infect 4, 733-739
48. Budriesi R, Ioan P, Micucci M, et al. (2010) Stop Fitan: Antispasmodic effect of natural extract of chestnut wood in guinea pig ileum and proximal colon smooth muscle. J Med Food 13, 1104-1110
49. McFarland LV (2010) Systematic review and meta-Analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16, 2202-2222
50. Rodrigues AC, Nardi RM, Bambirra EA, et al. (1996) Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol 81, 251-256
51. Czerucka D, Dahan S, Mograbi B, et al. (2001) Implication of mitogen-Activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect Immun 69, 1298-1305
52. Brandao RL, Castro IM, Bambirra EA, et al. (1998) Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 64, 564-568